We believe that the current manufacturing capability of astaxanthin producers utilizing microalgal or other natural manufacturing processes will not satisfy the growing demand for astaxanthin in human health applications and there will be a need for the synthetic production of nature-identical astaxanthin with high-purity, batch-to-batch consistency, and reliable large-volume supply at economical costs.

Production of nature-identical synthetic astaxanthin has multiple advantages over existing low-volume agricultural production methods. Nature-identical synthetic production methods can be scaled to accommodate growing global demand with consistent supply; and nature-identical synthetic production methods are clean, controlled, and allow for pharmaceutical-grade product purity.